期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Journal of Postgraduate Medicine LetPub Score 4.8
50 ratings
Rate
Reputation 5.8 Influence 3.6 Speed 6.4 | ||||||||||||||||
期刊簡稱 | J POSTGRAD MED | ||||||||||||||||
ISSN | 0022-3859 | ||||||||||||||||
E-ISSN | 9722-823 | ||||||||||||||||
h-index | 49 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 10.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.jpgmonline.com/ | ||||||||||||||||
在線稿件提交 | http://www.journalonweb.com/jpgm/ | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | Wolters Kluwer Medknow Publications | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | INDIA | ||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||
創刊年 | 1955 | ||||||||||||||||
每年文章數 | 31每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 96.55% | ||||||||||||||||
OA Related Info | APC: No APC waiver:No Other charges: No Keywords: medicine、surgery、clinical medicine Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble blind peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-3859%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 40 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Journal of Postgraduate Medicine] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:16:01 評論於 Contributors need to objectively evaluate whether the quality of their research work matches the level of the selected journal. Top journals have high requirements for the originality of submissions. The acceptance rate of top journals like Nature is less than 10%, and most submissions are rejected at the desk review stage by the handling editor(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:33:06 評論於 Please translate the following passage into English and Japanese, respectively, with titles ":" and ":"(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 23:29:32 評論於 Can I submit directly to top journals like Nature/Science? Will they provide feedback?(0) 讚! | 龙鳞孝礼 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 10:45:47 評論於 How many alternative journals are generally suitable for each journal gradient?(0) 讚! | 修然小公主 |
作者: 玉卿姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-10 19:28:15 評論於 Review Speed: 12.0 Experience Sharing: Talk about personal experience. This journal takes a minimum of 4 months from submission to revision before providing feedback. The initial review takes 4 months, and after revisions, it takes another 4 months. During this time, various excuses are given over email. Therefore, it is best to make a cautious decision before deciding to submit to this journal(0) 讚! | 玉卿姑娘 |
作者: 11111111 領域: 医学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-04-10 07:26:42 評論於 Talk about personal experience. This journal basically delayed 4 months from submission to minor revision. The first review lasted for 4 months, and it lasted for another 4 months after the revision returned. During the period of email contact, they put off with various reasons. So, if you decide to submit to this journal, it's best to make a careful decision. (2) 讚! | 11111111 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 10:35:39 評論於 Anyway, this bearish trend won't change, so as long as it doesn't fall, that's fortunate(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us